1
according to intensity of the conditioning regimen. Haematologica 2006; 91: 401. 15. Sencer SF, Haake RJ and Weisdorf DJ: Hemorrhagic cystitis after bone marrow trans- plantation. Risk factors and complications. Transplantation 1993; 56: 875. 16. Xu LP, Zhang HY, Huang XJ et al: Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft- versus-host disease. Chin Med J (Engl) 2007; 120: 1666. 17. Cheerva AC, Raj A, Bertolone SJ et al: BK virus- associated hemorrhagic cystitis in pediatric cancer patients receiving high-dose cyclophos- phamide. J Pediatr Hematol Oncol 2007; 29: 617. 18. Erard V, Kim HW, Corey L et al: BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106: 1130. 19. Corman JM, McClure D, Pritchett R et al: Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003; 169: 2200. 20. Chong KT, Hampson NB and Corman JM: Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 2005; 65: 649. 21. Yaghobi R, Ramzi M and Dehghani S: The role of different risk factors in clinical presentation of hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Transplant Proc 2009; 41: 2900. 22. Lukasewycz SJ, Smith AR, Rambachan A et al: Intractable hemorrhagic cystitis after hemato- poietic stem cell transplantationdis there a role for early urinary diversion in children? J Urol 2012; 188: 242. 23. Donahue LA and Frank IN: Intravesical formalin for hemorrhagic cystitis: analysis of therapy. J Urol 1989; 141: 809. 24. Goswami AK, Mahajan RK, Nath R et al: How safe is 1% alum irrigation in controlling intractable vesical hemorrhage? J Urol 1993; 149: 264. 25. Goel AK, Rao MS, Bhagwat AG et al: Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol 1985; 133: 956. 26. Bogris SL, Johal NS, Hussein I et al: Is it safe to use aluminum in the treatment of pediatric hemorrhagic cystitis? A case discussion of aluminum intoxication and review of the litera- ture. J Pediatr Hematol Oncol 2009; 31: 285. 27. Trigg ME, OReilly J, Rumelhart S et al: Prosta- glandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol 1990; 143: 92. 28. Lakhani A, Raptis A, Frame D et al: Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplant 1999; 24: 1259. 29. Savona MR, Newton D, Frame D et al: Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoi- etic stem cell transplant. Bone Marrow Trans- plant 2007; 39: 783. EDITORIAL COMMENT The authors are to be commended for this compre- hensive evaluation of a cohort of pediatric patients demonstrating hemorrhagic cystitis from a large database of patients undergoing chemotherapy. The experience presented corroborates our own experience (reference 22 in article) that high grade hemorrhagic cystitis not only is a devastating complication of chemotherapy causing immense pain and physical discomfort to the affected child, but also is a harbinger of disease specific mortality (10 of 15 children with grade IV HC died). Hyper- hydration, mesna coadministration with cyclophos- phamide and continuous bladder irrigation are mainstays of treatment for patients with lower grades of HC. However, grade IV HC remains an ongoing challenge. While the authors rightfully use conservative treatment options as initial therapy for HC, formalin was instilled in 26 patients. A longitudinal understanding of the sequelae of toxic formalin instillation in the pediatric popula- tion is unknown, and we would submit that options such as percutaneous nephrostomy placement for temporary urinary diversion should be consid- ered. This study underlines the need to proceed aggressively in controlling HC and the acute need to prospectively investigate the optimal treatment for HC. Aseem R. Shukla Division of Urology Children’s Hospital of Philadelphia Philadelphia, Pennsylvania 192 RISK FACTORS FOR HEMORRHAGIC CYSTITIS IN CHILDREN

Editorial Comment

  • Upload
    aseem-r

  • View
    217

  • Download
    3

Embed Size (px)

Citation preview

192 RISK FACTORS FOR HEMORRHAGIC CYSTITIS IN CHILDREN

according to intensity of the conditioningregimen. Haematologica 2006; 91: 401.

15. Sencer SF, Haake RJ and Weisdorf DJ:Hemorrhagic cystitis after bone marrow trans-plantation. Risk factors and complications.Transplantation 1993; 56: 875.

16. Xu LP, Zhang HY, Huang XJ et al: Hemorrhagiccystitis following hematopoietic stem celltransplantation: incidence, risk factors andassociation with CMV reactivation and graft-versus-host disease. Chin Med J (Engl) 2007;120: 1666.

17. Cheerva AC, Raj A, Bertolone SJ et al: BK virus-associated hemorrhagic cystitis in pediatriccancer patients receiving high-dose cyclophos-phamide. J Pediatr Hematol Oncol 2007; 29: 617.

18. Erard V, Kim HW, Corey L et al: BK DNA viral loadin plasma: evidence for an association withhemorrhagic cystitis in allogeneic hematopoieticcell transplant recipients. Blood 2005; 106: 1130.

19. Corman JM, McClure D, Pritchett R et al:Treatment of radiation induced hemorrhagic

cystitis with hyperbaric oxygen. J Urol 2003; 169:2200.

20. Chong KT, Hampson NB and Corman JM: Earlyhyperbaric oxygen therapy improves outcome forradiation-induced hemorrhagic cystitis. Urology2005; 65: 649.

21. Yaghobi R, Ramzi M and Dehghani S: The role ofdifferent risk factors in clinical presentation ofhemorrhagic cystitis in hematopoietic stem celltransplant recipients. Transplant Proc 2009; 41:2900.

22. Lukasewycz SJ, Smith AR, Rambachan A et al:Intractable hemorrhagic cystitis after hemato-poietic stem cell transplantationdis there a rolefor early urinary diversion in children? J Urol2012; 188: 242.

23. Donahue LA and Frank IN: Intravesical formalinfor hemorrhagic cystitis: analysis of therapy. JUrol 1989; 141: 809.

24. Goswami AK, Mahajan RK, Nath R et al:How safe is 1% alum irrigation in controlling

intractable vesical hemorrhage? J Urol 1993;149: 264.

25. Goel AK, Rao MS, Bhagwat AG et al: Intravesicalirrigation with alum for the control of massivebladder hemorrhage. J Urol 1985; 133: 956.

26. Bogris SL, Johal NS, Hussein I et al: Is it safe touse aluminum in the treatment of pediatrichemorrhagic cystitis? A case discussion ofaluminum intoxication and review of the litera-ture. J Pediatr Hematol Oncol 2009; 31: 285.

27. Trigg ME, O’Reilly J, Rumelhart S et al: Prosta-glandin E1 bladder instillations to control severehemorrhagic cystitis. J Urol 1990; 143: 92.

28. Lakhani A, Raptis A, Frame D et al: Intravesicularinstillation of E-aminocaproic acid for patientswith adenovirus-induced hemorrhagic cystitis.Bone Marrow Transplant 1999; 24: 1259.

29. Savona MR, Newton D, Frame D et al: Low-dosecidofovir treatment of BK virus-associatedhemorrhagic cystitis in recipients of hematopoi-etic stem cell transplant. Bone Marrow Trans-plant 2007; 39: 783.

EDITORIAL COMMENT

The authors are to be commended for this compre- conservative treatment options as initial therapy

hensive evaluation of a cohort of pediatric patientsdemonstrating hemorrhagic cystitis from a largedatabase of patients undergoing chemotherapy.The experience presented corroborates our ownexperience (reference 22 in article) that high gradehemorrhagic cystitis not only is a devastatingcomplication of chemotherapy causing immensepain and physical discomfort to the affected child,but also is a harbinger of disease specific mortality(10 of 15 children with grade IV HC died). Hyper-hydration, mesna coadministration with cyclophos-phamide and continuous bladder irrigation aremainstays of treatment for patients with lowergrades of HC. However, grade IV HC remains anongoing challenge. While the authors rightfully use

for HC, formalin was instilled in 26 patients. Alongitudinal understanding of the sequelae oftoxic formalin instillation in the pediatric popula-tion is unknown, and we would submit that optionssuch as percutaneous nephrostomy placementfor temporary urinary diversion should be consid-ered. This study underlines the need to proceedaggressively in controlling HC and the acute need toprospectively investigate the optimal treatmentfor HC.

Aseem R. ShuklaDivision of Urology

Children’s Hospital of Philadelphia

Philadelphia, Pennsylvania